Mortality and morbidity associated with illegal use of abortion pill: a prospective study in tertiary care center
DOI:
https://doi.org/10.18203/2320-6012.ijrms20161916Keywords:
Illegal use, Abortion pill, Medical abortion, Unintended pregnancyAbstract
Background: In India, medical method of abortion is allowed for first 7 weeks of intra uterine pregnancy. As per WHO it is safe and effective method for termination of early pregnancy under medical supervision. It is done by using mifepristone (200mg) and misoprostol (800mcg). These drugs are not for contraception but are abortion pills. Women use the abortion pills for unintended pregnancy inspite of using various method of contraception due to lack of knowledge, apprehension, poverty, denial, and ignorance of contraceptive use without any medical supervision (illegal use) and become victim of unsafe abortion. The main aim of this study was to find out mortality and morbidity associated with illegal use of abortion pill.
Methods: A prospective observational study was carried out in the department of obstetrics and gynaecology, TMMC and RC Moradabad, a tertiary care center with history of intake of abortion pill (mifepristone and misoprostol) for 1 year from 1st May 2015 to 1st April 2016 on 120 patients. Data was collected and analysed by percentage and proportions.
Results: Illegal use of abortion pill was more common among 30-39 years (55%) group of women and mostly were grand multiparous (81.67%). In most of the cases husband brought the pills (85%) from advice of chemist (70%).The most common presenting complaint was excessive bleeding per vaginum (66.3%). Most common complication was moderate anemia (38.3%).
Conclusions: The present study recommends medical method of abortion is safe and effective under medical supervision. Illegal use of abortion pills without supervision results in serious complications.
References
http://www.fogsi.org/ index.php? option= com_content & view=article & id=97& Itemid=16
Thaker RV, Deliwala KJ, Sha PT. Self-medication of abortion pill: women’ shealthin jeopardy. NHLJ Med Sci. 2014;3(1):26-31.
Guin G, Gupta A, Khare S, Chandra M, Kalkur S. A Study of Septic abortions: trend in tertiary hospital. J Obstet Gynecol India. 2005;55(3):257-60.
WHO: the prevention and management of unsafe abortions: Report of technical working group. Geneva. 1992.
Press information bureau, Govt. of India, Ministry of health and family welfare, 06-August-2013 14:26
http://www.who.int/ reproductivehealth/ publications/ unsafe_abortion/ 9789241501118/en/
Guidelines for medical abortion in India Material circulated by CASSA during the State-level Workshop on “Review of MTP Act 1971 in the context of Women’s Right to Safe Abortion and Halting Sex Selective Abortion, held in Chennai on 17th and 18th August 2007
Guin G, Gupta A, Khare S, Chandra M, Kalkur S. A Study of Septic abortions: trend in tertiary hospital. J Obstet Gynecol India. 2005;55(3):257-60.
Giri A, Srivastav VR, Suwal A, Sharma B. A Study of Complications following Self-administration with Medical Abortion Pills. NJOG. 2015;10(1).
Mishra N. Unprecedented use of medical abortion can be injurious to health. JEMS. 2013;2(8):856-9.
Thaker RV, Deliwala KJ, Shah PT. Selfmedication of abortion pill: women`s health in Jeopardy. NHLJMS. 2014;3:26-31.
Nivedita K, Fatima S. Is it safe to provide abortion pills over the counter? A study on outcome following self-medication with abortion pills. J Clin Diagn Res. 2015;9(1):1-4.
Jethani M, Yadav K, Muchhoria S, Sharma S, Monika. Self-Medicated Abortion- Care or Crime. JMSCR. 2015;03(09):7507-12.
NFHS-3 National Family Health Survey.
Hausknecht R. Mifepristone & Misoprostol for early medical abortion: 18 months experience in United States. Contraception. 2003;67:463-5.
Deshpande S, Yelikar K, Deshmukh A Kanade K. Comparative study of medical abortion by Mifepristone with vaginal Misoprostol in women < 49 days versus 50-63 days of amenorrhoea. J of Obst&Gyn of India. 2010;60(5):403-7.
Sedgh G, Singh S, Shah IH, Åhman E, Henshaw SK, Bankole A. Induced abortion: incidence and trends worldwide from 1995 to 2008, Lancet. 2012;379(9816):625-32.
India-ICMR International Consortium for Medical Abortion.m.icma.md/country/IN.
